Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Given Average Recommendation of "Buy" by Analysts

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) has earned an average recommendation of "Buy" from the six analysts that are covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $8.63.

A number of analysts recently weighed in on BIOX shares. Canaccord Genuity Group decreased their target price on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a "buy" rating on the stock in a report on Thursday, February 13th. Lake Street Capital lowered their price objective on Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating on the stock in a research report on Friday, February 7th. Finally, Oppenheimer dropped their price objective on Bioceres Crop Solutions from $8.00 to $7.00 and set an "outperform" rating for the company in a research note on Tuesday, April 22nd.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. lifted its stake in Bioceres Crop Solutions by 49.3% during the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company's stock worth $708,000 after purchasing an additional 29,693 shares during the last quarter. Ping Capital Management Inc. raised its holdings in shares of Bioceres Crop Solutions by 7.3% during the 4th quarter. Ping Capital Management Inc. now owns 44,000 shares of the company's stock valued at $268,000 after buying an additional 3,000 shares in the last quarter. Fourth Sail Capital LP lifted its position in Bioceres Crop Solutions by 16.6% in the 4th quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company's stock worth $22,490,000 after buying an additional 527,859 shares during the last quarter. Ballast Asset Management LP boosted its stake in Bioceres Crop Solutions by 23.5% in the fourth quarter. Ballast Asset Management LP now owns 431,887 shares of the company's stock worth $2,620,000 after buying an additional 82,187 shares in the last quarter. Finally, Jump Financial LLC purchased a new stake in Bioceres Crop Solutions in the fourth quarter worth approximately $72,000. Institutional investors own 17.68% of the company's stock.

Bioceres Crop Solutions Stock Performance

NASDAQ:BIOX traded up $0.08 during trading hours on Monday, reaching $4.53. The stock had a trading volume of 114,044 shares, compared to its average volume of 172,094. The stock has a market cap of $284.08 million, a P/E ratio of 226.61 and a beta of 0.40. The stock has a 50 day simple moving average of $4.35 and a 200 day simple moving average of $5.50. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.96 and a current ratio of 1.33. Bioceres Crop Solutions has a 12-month low of $3.51 and a 12-month high of $11.86.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last announced its quarterly earnings results on Wednesday, May 21st. The company reported ($0.02) EPS for the quarter, beating analysts' consensus estimates of ($0.10) by $0.08. The company had revenue of $59.60 million for the quarter, compared to analysts' expectations of $61.80 million. Bioceres Crop Solutions had a net margin of 0.58% and a return on equity of 0.68%. On average, research analysts forecast that Bioceres Crop Solutions will post -0.05 EPS for the current fiscal year.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.